Provides readers with a framework to understand and analyze several medicine pricing policies.
Through case studies from countries across geographies and income tiers, this book explores
the challenges and opportunities related to price control experiences. Studying global policies
this book discusses approaches, strategies, and the underlying pharmaceutical pricing practices
used to provide advice for formulating highly effective policies. Alongside the cases, this book
covers appropriate research methods for pricing analysis, the essential components of pricing
policy, data quality, and the generic structure of a pharmaceutical pricing policy.
Table of Contents
1. An update on pharmaceutical pricing policies: latest research and evidence synthesis
2. Research methods used in pharmaceutical pricing research
3. Implementation of pharmaceutical pricing policies in NZ: Lessons learned
4. Australia's progress in pharmaceutical pricing policies
5. Components of a successful pricing policy in high-income countries
6. Outlining the components of a pricing policy for the US: a proposal
7. Lessons learned from China on medicine pricing policies
8. Synthesis chapter on EU Pharmaceutical pricing policies
9. Challenges in Low and Middle-Income Countries regarding pharmaceutical pricing policies
10. South Africa's medicine pricing policies: implementation strategies and models
11. Pharmaceutical pricing policies in countries with price control (Pakistan, India, Bangladesh): lessons learned
12. Challenges in the implementation of pharmaceutical pricing policies
13. Issues with medicine pricing data about pharmaceutical pricing policies in LMICs
14. Optimal pharmaceutical pricing policies in low and middle-income countries
15. Formulating a medicines pricing policy of a country: essential components, what to include
16. Synthesis, conclusion, and future recommendation
